Biomaterials Science Lectureship symposium

Biomaterials Science is very happy to be the official journal of the European Society of Biomaterials and sponsor a session at ESB 2021.

Biomaterials Science is published on a not-for-profit basis by the Royal Society of Chemistry and publishes high impact work focused on exploring the design, function, and interactions of biomaterials. Its scope encompasses new concepts in biomaterials design, studies into the interaction of biomaterials with the body, and the use of materials to answer fundamental biological questions. The journal is led by Editor-in-Chief Jianjun Cheng, alongside an international Editorial Board including expert Associate Editors.

This session features presentation of the 2021 Biomaterials Science lectureship to Nasim Annabi (UCLA).

We are happy to have Khuloud Al-Jamal as second keynote speaker in the session.

Nasim Annabi, Prof. Dr.

Department of Chemical and Biomolecular Engineering, University of California, Los Angeles (UCLA), USA

Nasim Annabi is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at University of California, Los Angeles (UCLA). She received a PhD in Chemical Engineering from the University of Sydney (Australia). From 2011-2014, she was a postdoctoral fellow at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering. Before joining UCLA in 2018, she was an Assistant Professor in the Department of Chemical Engineering at Northeastern University. Dr. Annabi’s group has expertise in the design and engineering of advanced biomaterials for applications in regenerative medicine. In addition, her research team has devised innovative strategies for the development of advanced bioadhesives and surgical sealants with high clinical translation for surgical applications. Dr. Annabi has published over 136 articles in peer-reviewed journals. She has been cited over 13,338 times and her H index is already at 58. Her innovations have resulted in 15 patents and generated significant commercial interest. Dr Annabi has been recognized with several national and international awards including the 2021 Young Investigator Award from the Society for Biomaterials (SFB), the 2020 Nanoscale Science and Engineering Forum (NSEF) Young Investigator Award of American Institute of Chemical Engineers (AIChE), the Australian Prestigious Endeavour Award, and the National Health and Medical Research Council Early Career Award. Her team has received major grants from the National Institutes of Health (NIH), the Department of Defense (DOD) and the American Heart Association (AHA).

Khuloud Al-Jamal, Prof. Dr.

Chair of Drug Delivery & Nanomedicine, School of Cancer and Pharmaceutical Sciences, King’s College London, United Kingdom

Khuloud Al-Jamal is a Chair of Drug Delivery & Nanomedicine and Head of Medicines Developments at the Institute of Pharmaceutical Science, King’s College London. She has developed an extensive experience in designing and developing novel nanoscale delivery systems including dendrimers, liposomes, quantum Dots, polymers, viral vectors, chemically functionalised carbon nanotubes and graphene oxide. Her current work involves pre-clinical translation nanomedicines with special interests in brain diseases and cancer.  She received several awards including the Maplethrope Research and Teaching Award, BBSRC New Investigator Award, Royal Pharmaceutical Society of Great Britain Science Award, the Controlled Release Society Nanomedicine and Nanoscale Delivery Focus Group Young Investigator Award and Wellcome Trust Image Awards.  She is a member of the General of Pharmaceutical Council. She is a management board member and is on the steering committee of the London Centre of Nanotechnology and the Children Brain Tumour Drug Delivery Consortium. She is on the Editorial Board of Biomaterials Science (RSC), MedBioMed (Wiley), Scientific Reports (Nature Publisher) and Journal of Drug Targeting. She is a member of the General of Pharmaceutical Council and a Fellow of Royal Society of Chemistry.

Important Dates

Deadline Early Bird Registration
Virtual conference
24 August 2021

Late Registration
Virtual conference
from 25 August 2021

ESB 2021
5–9 September 2021
as fully virtual conferencel

Biomechanics part:
9 September 2021

Conference Status with respect to the Coronavirus pandemic

In the last two weeks, despite the great progress of the vaccination program, the number of coronavirus infections in Portugal has risen significantly due to the Delta variant of the virus. The nationwide 7-day incidence of 110.2 (as of July 1, 2021; source: Johns Hopkins University) is well above the critical limit of 50 newly infected persons per 100,000 inhabitants, per week. 

Taking into consideration the health and safety of all presenters, exhibitors and attendees, and the importance of assuring the quality of the Conference Program, the Organising Committee has taken the difficult decision to move ESB2021 to a fully virtual format, from September 5-9, 2021.

More information

Organizer

esb-300x154-1.jpg

Contact

logo_kit_gross.png

K.I.T. Group GmbH Dresden
Bautzner Str. 117-119
01099 Dresden, Germany